PubMed@dpavot:32491073_en_relations
Annnotations
ENG_RE
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T0 | 12-19 | DOID_4 | denotes | disease |
T1 | 26-34 | DOID_0080600 | denotes | COVID-19 |
T2 | 116-124 | DOID_0080600 | denotes | COVID-19 |
T3 | 241-249 | DOID_0080600 | denotes | COVID-19 |
T4 | 283-294 | HP_0012819 | denotes | myocarditis |
T5 | 283-294 | DOID_820 | denotes | myocarditis |
T6 | 377-391 | CHEBI_35457 | denotes | ACE inhibitors |
T7 | 381-391 | CHEBI_35222 | denotes | inhibitors |
T8 | 396-407 | CHEBI_2719 | denotes | angiotensin |
T9 | 450-462 | HP_0000822 | denotes | hypertension |
T10 | 450-462 | DOID_10763 | denotes | hypertension |
T11 | 467-480 | HP_0001635 | denotes | heart failure |
T12 | 484-492 | DOID_0080600 | denotes | COVID-19 |
T13 | 562-570 | DOID_0080600 | denotes | COVID-19 |
R13 | T12 | T8 | no_relation | COVID-19,angiotensin |
R14 | T13 | T6 | no_relation | COVID-19,ACE inhibitors |
R15 | T13 | T8 | no_relation | COVID-19,angiotensin |
R0 | T0 | T6 | effect | disease,ACE inhibitors |
R1 | T0 | T8 | effect | disease,angiotensin |
R2 | T1 | T6 | effect | COVID-19,ACE inhibitors |
R3 | T1 | T8 | effect | COVID-19,angiotensin |
R4 | T2 | T6 | effect | COVID-19,ACE inhibitors |
R5 | T2 | T8 | effect | COVID-19,angiotensin |
R6 | T3 | T6 | effect | COVID-19,ACE inhibitors |
R7 | T3 | T8 | effect | COVID-19,angiotensin |
R8 | T5 | T6 | effect | myocarditis,ACE inhibitors |
R9 | T5 | T8 | effect | myocarditis,angiotensin |
R10 | T10 | T6 | no_relation | hypertension,ACE inhibitors |
R11 | T10 | T8 | no_relation | hypertension,angiotensin |
R12 | T12 | T6 | no_relation | COVID-19,ACE inhibitors |
ENG_RE_Diana
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T0 | 12-19 | DOID_4 | denotes | disease |
T1 | 26-34 | DOID_0080600 | denotes | COVID-19 |
T10 | 450-462 | DOID_10763 | denotes | hypertension |
T11 | 467-480 | HP_0001635 | denotes | heart failure |
T12 | 484-492 | DOID_0080600 | denotes | COVID-19 |
T13 | 562-570 | DOID_0080600 | denotes | COVID-19 |
T2 | 116-124 | DOID_0080600 | denotes | COVID-19 |
T3 | 241-249 | DOID_0080600 | denotes | COVID-19 |
T4 | 283-294 | HP_0012819 | denotes | myocarditis |
T5 | 283-294 | DOID_820 | denotes | myocarditis |
T6 | 377-391 | CHEBI_35457 | denotes | ACE inhibitors |
T7 | 381-391 | CHEBI_35222 | denotes | inhibitors |
T8 | 396-407 | CHEBI_2719 | denotes | angiotensin |
T9 | 450-462 | HP_0000822 | denotes | hypertension |
T14 | 0-24 | DOID_0080600 | denotes | Coronavirus disease 2019 |
R0 | T0 | T6 | effect | disease,ACE inhibitors |
R1 | T0 | T8 | effect | disease,angiotensin |
R10 | T10 | T6 | effect | hypertension,ACE inhibitors |
R11 | T10 | T8 | effect | hypertension,angiotensin |
R12 | T12 | T6 | effect | COVID-19,ACE inhibitors |
R13 | T12 | T8 | effect | COVID-19,angiotensin |
R14 | T13 | T6 | effect | COVID-19,ACE inhibitors |
R15 | T13 | T8 | effect | COVID-19,angiotensin |
R2 | T1 | T6 | effect | COVID-19,ACE inhibitors |
R3 | T1 | T8 | effect | COVID-19,angiotensin |
R4 | T2 | T6 | effect | COVID-19,ACE inhibitors |
R5 | T2 | T8 | effect | COVID-19,angiotensin |
R6 | T3 | T6 | effect | COVID-19,ACE inhibitors |
R7 | T3 | T8 | effect | COVID-19,angiotensin |
R8 | T5 | T6 | effect | myocarditis,ACE inhibitors |
R9 | T5 | T8 | effect | myocarditis,angiotensin |
R16 | T4 | T3 | effect | myocarditis,COVID-19 |
R17 | T5 | T3 | effect | myocarditis,COVID-19 |
R18 | T11 | T8 | effect | heart failure,angiotensin |
R19 | T11 | T6 | effect | heart failure,ACE inhibitors |
R20 | T9 | T8 | effect | hypertension,angiotensin |
R21 | T9 | T6 | effect | hypertension,ACE inhibitors |
RELASIGEBLAH7hhaider5
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T0 | 12-19 | DOID_4 | denotes | disease |
T1 | 26-34 | DOID_0080600 | denotes | COVID-19 |
T10 | 450-462 | DOID_10763 | denotes | hypertension |
T11 | 467-480 | HP_0001635 | denotes | heart failure |
T12 | 484-492 | DOID_0080600 | denotes | COVID-19 |
T13 | 562-570 | DOID_0080600 | denotes | COVID-19 |
T2 | 116-124 | DOID_0080600 | denotes | COVID-19 |
T3 | 241-249 | DOID_0080600 | denotes | COVID-19 |
T4 | 283-294 | HP_0012819 | denotes | myocarditis |
T5 | 283-294 | DOID_820 | denotes | myocarditis |
T6 | 377-391 | CHEBI_35457 | denotes | ACE inhibitors |
T7 | 381-391 | CHEBI_35222 | denotes | inhibitors |
T8 | 396-407 | CHEBI_2719 | denotes | angiotensin |
T9 | 450-462 | HP_0000822 | denotes | hypertension |
R0 | T0 | T6 | effect | disease,ACE inhibitors |
R1 | T0 | T8 | effect | disease,angiotensin |
R10 | T10 | T6 | no_relation | hypertension,ACE inhibitors |
R11 | T10 | T8 | effect | hypertension,angiotensin |
R12 | T12 | T6 | effect | COVID-19,ACE inhibitors |
R13 | T12 | T8 | effect | COVID-19,angiotensin |
R14 | T13 | T6 | no_relation | COVID-19,ACE inhibitors |
R15 | T13 | T8 | effect | COVID-19,angiotensin |
R2 | T1 | T6 | effect | COVID-19,ACE inhibitors |
R3 | T1 | T8 | effect | COVID-19,angiotensin |
R4 | T2 | T6 | effect | COVID-19,ACE inhibitors |
R5 | T2 | T8 | effect | COVID-19,angiotensin |
R6 | T3 | T6 | effect | COVID-19,ACE inhibitors |
R7 | T3 | T8 | effect | COVID-19,angiotensin |
R8 | T5 | T6 | effect | myocarditis,ACE inhibitors |
R9 | T5 | T8 | effect | myocarditis,angiotensin |
ENG_RE_pruas
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 26-34 | DOID_0080600 | denotes | COVID-19 |
T10 | 450-462 | DOID_10763 | denotes | hypertension |
T11 | 467-480 | HP_0001635 | denotes | heart failure |
T12 | 484-492 | DOID_0080600 | denotes | COVID-19 |
T13 | 562-570 | DOID_0080600 | denotes | COVID-19 |
T2 | 116-124 | DOID_0080600 | denotes | COVID-19 |
T3 | 241-249 | DOID_0080600 | denotes | COVID-19 |
T4 | 283-294 | HP_0012819 | denotes | myocarditis |
T5 | 283-294 | DOID_820 | denotes | myocarditis |
T9 | 450-462 | HP_0000822 | denotes | hypertension |
T14 | 0-24 | DOID_0080600 | denotes | Coronavirus disease 2019 |
T15 | 191-219 | HP_0001626 | denotes | Cardiovascular comorbidities |
T16 | 396-425 | CHEBI_61016 | denotes | angiotensin receptor blockers |
T6 | 377-391 | CHEBI_35457 | denotes | ACE inhibitors |
R10 | T10 | T6 | negative | hypertension,ACE inhibitors |
R11 | T10 | T6 | negative | hypertension,ACE inhibitors |
R12 | T16 | T9 | negative | angiotensin receptor blockers,hypertension |
R13 | T16 | T11 | negative | angiotensin receptor blockers,heart failure |
R14 | T6 | T10 | negative | ACE inhibitors,hypertension |
R15 | T6 | T11 | negative | ACE inhibitors,heart failure |
R16 | T15 | T3 | effect | Cardiovascular comorbidities,COVID-19 |
R17 | T5 | T3 | effect | myocarditis,COVID-19 |
R18 | T5 | T12 | effect | myocarditis,COVID-19 |
R19 | T15 | T12 | effect | Cardiovascular comorbidities,COVID-19 |
R20 | T15 | T13 | effect | Cardiovascular comorbidities,COVID-19 |
R21 | T15 | T2 | effect | Cardiovascular comorbidities,COVID-19 |
R22 | T15 | T1 | effect | Cardiovascular comorbidities,COVID-19 |
R23 | T15 | T14 | effect | Cardiovascular comorbidities,Coronavirus disease 2019 |
R24 | T5 | T13 | effect | myocarditis,COVID-19 |
R25 | T5 | T2 | effect | myocarditis,COVID-19 |
R26 | T5 | T1 | effect | myocarditis,COVID-19 |
R27 | T5 | T14 | effect | myocarditis,Coronavirus disease 2019 |
ENG_RE_mabarros
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T0 | 12-19 | DOID_4 | denotes | disease |
T1 | 26-34 | DOID_0080600 | denotes | COVID-19 |
T10 | 450-462 | DOID_10763 | denotes | hypertension |
T11 | 467-480 | HP_0001635 | denotes | heart failure |
T12 | 484-492 | DOID_0080600 | denotes | COVID-19 |
T13 | 562-570 | DOID_0080600 | denotes | COVID-19 |
T2 | 116-124 | DOID_0080600 | denotes | COVID-19 |
T3 | 241-249 | DOID_0080600 | denotes | COVID-19 |
T4 | 283-294 | HP_0012819 | denotes | myocarditis |
T5 | 283-294 | DOID_820 | denotes | myocarditis |
T6 | 377-391 | CHEBI_35457 | denotes | ACE inhibitors |
T7 | 381-391 | CHEBI_35222 | denotes | inhibitors |
T8 | 396-407 | CHEBI_2719 | denotes | angiotensin |
T9 | 450-462 | HP_0000822 | denotes | hypertension |
R0 | T0 | T6 | effect | disease,ACE inhibitors |
R1 | T0 | T8 | effect | disease,angiotensin |
R10 | T10 | T6 | no_relation | hypertension,ACE inhibitors |
R11 | T10 | T8 | no_relation | hypertension,angiotensin |
R12 | T12 | T6 | no_relation | COVID-19,ACE inhibitors |
R13 | T12 | T8 | no_relation | COVID-19,angiotensin |
R14 | T13 | T6 | no_relation | COVID-19,ACE inhibitors |
R15 | T13 | T8 | no_relation | COVID-19,angiotensin |
R2 | T1 | T6 | effect | COVID-19,ACE inhibitors |
R3 | T1 | T8 | effect | COVID-19,angiotensin |
R4 | T2 | T6 | effect | COVID-19,ACE inhibitors |
R5 | T2 | T8 | effect | COVID-19,angiotensin |
R6 | T3 | T6 | effect | COVID-19,ACE inhibitors |
R7 | T3 | T8 | effect | COVID-19,angiotensin |
R8 | T5 | T6 | effect | myocarditis,ACE inhibitors |
R9 | T5 | T8 | effect | myocarditis,angiotensin |
R16 | T3 | T5 | effect | COVID-19,myocarditis |